{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:18:20Z","timestamp":1791461900594,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471611"],"award-info":[{"award-number":["81471611"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671610"],"award-info":[{"award-number":["81671610"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471610"],"award-info":[{"award-number":["81471610"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.cyto.2018.06.032","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T19:47:05Z","timestamp":1531165625000},"page":"144-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Interleukin 29 inhibits RANKL-induced osteoclastogenesis via activation of JNK and STAT, and inhibition of NF-\u03baB and NFATc1"],"prefix":"10.1016","volume":"113","author":[{"given":"Qiuyue","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqing","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaojia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meilang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cyto.2018.06.032_b0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.cyto.2018.06.032_b0010","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/jir.2010.0078","article-title":"Interferon-lambda: a new addition to an old family","volume":"30","author":"Donnelly","year":"2010","journal-title":"J. Interferon Cytokine Res."},{"issue":"8","key":"10.1016\/j.cyto.2018.06.032_b0015","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/gene.2009.72","article-title":"Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines","volume":"10","author":"Witte","year":"2009","journal-title":"Genes Immun."},{"key":"10.1016\/j.cyto.2018.06.032_b0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.critrevonc.2016.08.002","article-title":"The role of IL-29 in immunity and cancer","volume":"106","author":"Kelm","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"5","key":"10.1016\/j.cyto.2018.06.032_b0025","doi-asserted-by":"crossref","first-page":"R228","DOI":"10.1186\/ar4067","article-title":"Interleukin-29 modulates proinflammatory cytokine production in synovial inflammation of rheumatoid arthritis","volume":"14","author":"Wang","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cyto.2018.06.032_b0030","doi-asserted-by":"crossref","first-page":"9631510","DOI":"10.1155\/2016\/9631510","article-title":"Interleukin-29 enhances synovial inflammation and cartilage degradation in osteoarthritis","volume":"2016","author":"Xu","year":"2016","journal-title":"Mediators Inflamm."},{"issue":"6","key":"10.1016\/j.cyto.2018.06.032_b0035","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1189\/jlb.0509347","article-title":"Modulation of human plasmacytoid DC function by IFN-lambda1 (IL-29)","volume":"86","author":"Megjugorac","year":"2009","journal-title":"J. Leukoc. Biol."},{"issue":"12","key":"10.1016\/j.cyto.2018.06.032_b0040","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1089\/jir.2015.0169","article-title":"Immune cell profiling of IFN-lambda response shows pDCs express highest level of IFN-lambda R1 and are directly responsive via the JAK-STAT pathway","volume":"36","author":"Kelly","year":"2016","journal-title":"J. Interferon Cytokine Res."},{"issue":"1","key":"10.1016\/j.cyto.2018.06.032_b0045","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/eji.201444903","article-title":"IFN-lambda-mediated IL-12 production in macrophages induces IFN-gamma production in human NK cells","volume":"45","author":"de Groen","year":"2015","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2018.06.032_b0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1189\/jlb.1208761","article-title":"Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses","volume":"86","author":"Li","year":"2009","journal-title":"J. Leukoc. Biol."},{"issue":"5","key":"10.1016\/j.cyto.2018.06.032_b0055","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.coi.2011.07.007","article-title":"IFN-lambdas","volume":"23","author":"Kotenko","year":"2011","journal-title":"Curr. Opin. Immunol."},{"issue":"8","key":"10.1016\/j.cyto.2018.06.032_b0060","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1089\/jir.2010.0058","article-title":"Interferon-lambda as a potential therapeutic agent in cancer treatment","volume":"30","author":"Steen","year":"2010","journal-title":"J. Interferon Cytokine Res.: Off. J Int. Soc. Interferon Cytokine Res."},{"issue":"3","key":"10.1016\/j.cyto.2018.06.032_b0065","doi-asserted-by":"crossref","first-page":"R88","DOI":"10.1186\/ar3363","article-title":"Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity","volume":"13","author":"Wu","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.cyto.2018.06.032_b0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2362.2011.02557.x","article-title":"Profiling the expression of interleukin (IL)-28 and IL-28 receptor alpha in systemic lupus erythematosus patients","volume":"42","author":"Lin","year":"2012","journal-title":"Eur. J. Clin. Invest."},{"issue":"204","key":"10.1016\/j.cyto.2018.06.032_b0075","doi-asserted-by":"crossref","first-page":"204ra129","DOI":"10.1126\/scitranslmed.3006245","article-title":"IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis","volume":"5","author":"Wolk","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.cyto.2018.06.032_b0080","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/cei.12865","article-title":"Expression of type III interferons (IFNlambdas) and their receptor in Sjogren's syndrome","volume":"186","author":"Apostolou","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2018.06.032_b0085","doi-asserted-by":"crossref","first-page":"R170","DOI":"10.1186\/ar4357","article-title":"IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the synovial fibroblasts from rheumatoid arthritis patients","volume":"15","author":"Xu","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"6812","key":"10.1016\/j.cyto.2018.06.032_b0090","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/35046102","article-title":"T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma","volume":"408","author":"Takayanagi","year":"2000","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.cyto.2018.06.032_b0095","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1084\/jem.190.12.1741","article-title":"Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors","volume":"190","author":"Arai","year":"1999","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.cyto.2018.06.032_b0100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"issue":"6717","key":"10.1016\/j.cyto.2018.06.032_b0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.cyto.2018.06.032_b0110","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrrheum.2012.153","article-title":"Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment","volume":"8","author":"Schett","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.cyto.2018.06.032_b0115","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nri2062","article-title":"Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems","volume":"7","author":"Takayanagi","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2018.06.032_b0120","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.4049\/jimmunol.1003487","article-title":"IL-33 shifts the balance from osteoclast to alternatively activated macrophage differentiation and protects from TNF-alpha-mediated bone loss","volume":"186","author":"Zaiss","year":"2011","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.cyto.2018.06.032_b0125","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.4049\/jimmunol.181.8.5720","article-title":"IL-23 inhibits osteoclastogenesis indirectly through lymphocytes and is required for the maintenance of bone mass in mice","volume":"181","author":"Quinn","year":"2008","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2018.06.032_b0130","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20051150","article-title":"Autoamplification of NFATc1 expression determines its essential role in bone homeostasis","volume":"202","author":"Asagiri","year":"2005","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.cyto.2018.06.032_b0135","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1083\/jcb.148.2.333","article-title":"Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts","volume":"148","author":"Miyazaki","year":"2000","journal-title":"J. Cell Biol."},{"issue":"Suppl 3","key":"10.1016\/j.cyto.2018.06.032_b0140","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1186\/ar581","article-title":"Signaling crosstalk between RANKL and interferons in osteoclast differentiation","volume":"4","author":"Takayanagi","year":"2002","journal-title":"Arthritis Res."},{"issue":"1","key":"10.1016\/j.cyto.2018.06.032_b0145","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1172\/JCI30074","article-title":"IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation","volume":"117","author":"Gao","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.cyto.2018.06.032_b0150","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1089\/107999000414826","article-title":"IFN-gamma enhances osteoclast generation in cultures of peripheral blood from osteopetrotic patients and normalizes superoxide production","volume":"20","author":"Madyastha","year":"2000","journal-title":"J. Interferon Cytokine Res.: Official J. Int. Soc. Interferon Cytokine Res."},{"issue":"11","key":"10.1016\/j.cyto.2018.06.032_b0155","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1002\/eji.200526141","article-title":"IFN-gamma-producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL","volume":"35","author":"Kotake","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2018.06.032_b0160","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12967-014-0330-y","article-title":"Exogenous IFN-beta regulates the RANKL-c-Fos-IFN-beta signaling pathway in the collagen antibody-induced arthritis model","volume":"12","author":"Zhao","year":"2014","journal-title":"J. Transl. Med."},{"issue":"11","key":"10.1016\/j.cyto.2018.06.032_b0165","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nrrheum.2012.167","article-title":"New developments in osteoimmunology","volume":"8","author":"Takayanagi","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cyto.2018.06.032_b0170","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","article-title":"How cells respond to interferons","volume":"67","author":"Stark","year":"1998","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.cyto.2018.06.032_b0175","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1146\/annurev.immunol.19.1.623","article-title":"IRF family of transcription factors as regulators of host defense","volume":"19","author":"Taniguchi","year":"2001","journal-title":"Annu. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.cyto.2018.06.032_b0180","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/1756-185X.12747","article-title":"Interleukin-29 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via MAPK signaling pathways","volume":"18","author":"Xu","year":"2015","journal-title":"Int. J. Rheum. Dis."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618302825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618302825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:51:19Z","timestamp":1760907079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466618302825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":36,"alternative-id":["S1043466618302825"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2018.06.032","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin 29 inhibits RANKL-induced osteoclastogenesis via activation of JNK and STAT, and inhibition of NF-\u03baB and NFATc1","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2018.06.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}